Orally administered controlled drug delivery system providing temporal and spatial control
Abstract
A pharmaceutical composition in the form of tablets or capsules that provides a combination of temporal and spatial control of the controlled administration of the drug to a patient, for effective therapeutic results. The pharmaceutical composition it comprises a drug, a gas generating component, a foaming agent, a viscosity imparting agent and, optionally, a gel-forming polymer. The fluffing agent belongs to a class of compounds known as superdisintegrants (for example, cross-linked polyvinylpyrrolidone or sodium carboxymethylcellulose). Initially the delivery agent of viscosity and, after this, the gel-forming polymer forms a hydrated gel matrix that traps the gas, causing The hydrated gel matrix of the tablet creates a sinuous diffusion path of the drug, resulting in the release prolonged drug (temporary control). The preferred formulations of ciprofloxacin once a day comprises 69.9% of Ciprofloxacin base, 0.34% Sodium alginate, 1.03% Xanthan gum, 13.7% sodium bicarbonate, 12.1% cross-linked polyvinylpyrrolidone and, optionally, other pharmaceutical excipients, the formulations are in the form of a tablet coated or uncoated or a capsule.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
108 members in 51 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 15293298 | United States of America | A | |
| 15293298 | United States of America | A | |
| 9900078 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 9900078 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 152932 | – | – | – |
| 9900078 | – | – | – |
| US19980152932 | – | – | – |
| WO1999IB00078 | – | – | – |
Members108
| Document | Office | Kind | |
|---|---|---|---|
| CA2292600A1 | Canada | A1 | |
| CA2601462A1 | Canada | A1 | |
| ID20400A | Indonesia | A | |
| WO9855075A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU8057398A | Australia | A | |
| MA24560A1 | Morocco | A1 | |
| ZA984791B | South Africa | B | |
| WO9855075A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO995768D0 | Norway | D0 | |
| NO995768L | Norway | L | |
| CA2343760A1 | Canada | A1 | |
| WO0015198A1 | World Intellectual Property Organization (WIPO) | A1 | |
| ZA995839B | South Africa | B | |
| UY25710A1 | Uruguay | A1 | |
| AU1779499A | Australia | A | |
| EP0998251A2 | European Patent Office (EPO) | A2 | |
| PA8452401A1 | Panama | A1 | |
| PA8458701A1 | Panama | A1 | |
| EA199901115A1 | Eurasian Patent Organization (EAPO) | A1 | |
| SV1999000152A | El Salvador | A | |
| CN1259040A | China | A | |
| CO4940361A1 | Colombia | A1 | |
| PL337531A1 | Poland | A1 | |
| EP0998251A4 | European Patent Office (EPO) | A4 | |
| PE20001058A1 | Peru | A1 | |
| US6130254A | United States of America | A | |
| BR9809969A | Brazil | A | |
| KR20010013415A | Republic of Korea | A | |
| GT199900151A | Guatemala | A | |
| HN1999000158A | Honduras | A | |
| IS5885A | Iceland | A | |
| NO20011276D0 | Norway | D0 | |
| AP2001002098A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| AR014877A1 | Argentina | A1 | |
| NO20011276LThis record | Norway | L | |
| EP1107741A1 | European Patent Office (EPO) | A1 | |
| TR2001000731T2 | Türkiye | T2 | |
| TR200100731T2 | Türkiye | T2 | |
| IN186245B | India | B | |
| IN186250B | India | B | |
| US6261601B1 | United States of America | B1 | |
| KR20010075079A | Republic of Korea | A | |
| CZ2001901A3 | Czechia | A3 | |
| NZ501634A | New Zealand | A | |
| SK3472001A3 | Slovakia | A3 | |
| BR9913696A | Brazil | A | |
| ID29843A | Indonesia | A | |
| EA200100346A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2001520677A | Japan | A | |
| BG105339A | Bulgaria | A | |
| CN1325299A | China | A | |
| PL346798A1 | Poland | A1 | |
| CO5130022A1 | Colombia | A1 | |
| HU0103632A2 | Hungary | A2 | |
| HUP0103632A2 | Hungary | A2 | |
| HK1037967A | Hong Kong, China | A | |
| HK1037967A1 | Hong Kong, China | A1 | |
| IL141977A0 | Israel | A0 | |
| IL141977D0 | Israel | D0 | |
| US6365630B1 | United States of America | B1 | |
| HRP20010187A2 | Croatia | A2 | |
| MXPA01002634A | Mexico | A | |
| EE200100153A | Estonia | A | |
| JP2002524494A | Japan | A | |
| US2002106339A1 | United States of America | A1 | |
| AR022672A1 | Argentina | A1 | |
| NZ513045A | New Zealand | A | |
| JP2003034137A | Japan | A | |
| EP1281397A1 | European Patent Office (EPO) | A1 | |
| AU758324B2 | Australia | B2 | |
| NZ510487A | New Zealand | A | |
| YU19501A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| EP1107741B1 | European Patent Office (EPO) | B1 | |
| AT245414T | Austria | T | |
| ATE245414T1 | Austria | T1 | |
| DE69909801D1 | Germany | D1 | |
| DK1107741T3 | Denmark | T3 | |
| EA200300847A1 | Eurasian Patent Organization (EAPO) | A1 | |
| PT1107741E | Portugal | E | |
| SI1107741T1 | Slovenia | T1 | |
| ES2204098T3 | Spain | T3 | |
| GEP20043216B | Georgia | B | |
| EA004443B1 | Eurasian Patent Organization (EAPO) | B1 | |
| HRP20010187B1 | Croatia | B1 | |
| NZ523747A | New Zealand | A | |
| DE69909801T2 | Germany | T2 | |
| JP2004217670A | Japan | A | |
| JP3554339B2 | Japan | B2 | |
| OA11652A | African Intellectual Property Organization (OAPI) | A | |
| CN1186013C | China | C | |
| TNSN98077A1 | Tunisia | A1 | |
| US2005058709A1 | United States of America | A1 | |
| CU23040A3 | Cuba | A3 | |
| TWI234467B | Taiwan Province of China | B | |
| HU0103632A3 | Hungary | A3 | |
| HUP0103632A3 | Hungary | A3 | |
| EA005767B1 | Eurasian Patent Organization (EAPO) | B1 | |
| UA73287C2 | Ukraine | C2 | |
| US6942870B2 | United States of America | B2 | |
| US6960356B1 | United States of America | B1 |
Numbers
- Publication, DOCDB
- 20011276
- Publication, EPODOC
- NO20011276L
- Application
- 1276
- Application, DOCDB
- 20011276
- Application, EPODOC
- NO20010001276
Titles2
- Norwegian
- Oralt administrert kontrollert legemiddel-leveringssystem som tilveiebringer temporal og spatial kontroll
- English
- Orally administered controlled drug delivery system providing temporal and spatial control
Classification
- CPC, 16
- A61K9/0065
- A61P11/00
- A61P19/00
- A61P19/06
- A61P29/00
- A61P3/00
- A61P31/00
- A61P31/10
- A61P31/12
- A61P33/00
- A61P35/00
- A61P3/04
- A61P3/06
- A61P37/00
- A61P37/06
- A61P9/00
- IPC, 32
- A61K9 00
- A61K9 22
- A61K9 52
- A61K31 341
- A61K31 401
- A61K31 4709
- A61K31 52
- A61K31 554
- A61K45 08
- A61K47 00
- A61K47 02
- A61K47 04
- A61K47 12
- A61K47 18
- A61K47 20
- A61K47 22
- A61K47 30
- A61K47 32
- A61K47 36
- A61K47 38
- A61P3 04
- A61P3 06
- A61P9 00
- A61P11 00
- A61P19 06
- A61P29 00
- A61P31 00
- A61P31 10
- A61P31 12
- A61P33 00
- A61P35 00
- A61P37 06